Clinical Trials Browser

OTHER × Hematologic Neoplasms × Oxidoreductases × Clear all

NCT04745910 2026-05-06

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Phase 4 Completed

Other hematologic neoplasm

Tumor Lysis Syndrome, Hematologic Neoplasms